Roth Capital Starts Acadia Pharmaceuticals (ACAD) at Buy
Tweet Send to a FriendGet Alerts ACAD Hot Sheet
Price: $14.19 +2.90%
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
7 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade ACAD Now!
Roth Capital initiates coverage on Acadia Pharmaceuticals (NASDAQ: ACAD) with a Buy. PT $3.00.
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $1.45 yesterday, with a 52 week range of $0.90-$2.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Acadia Pharmaceuticals click here. For more ratings news on Acadia Pharmaceuticals click here.
Shares of Acadia Pharmaceuticals closed at $1.45 yesterday, with a 52 week range of $0.90-$2.30.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Starts Kodiak Oil & Gas (KOG) at Hold
- Topeka Capital Starts InvenSense (INVN) at Buy
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
Create E-mail Alert Related Categories
New CoverageRelated Entities
Roth Capital
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
